BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4138646)

  • 1. Immunization against Pseudomonas in infection after thermal injury.
    Wesley J; Fisher A; Fisher MW
    J Infect Dis; 1974 Nov; 130 Suppl(0):S152-8. PubMed ID: 4138646
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of immunotherapy for infections due to Pseudomonas aeruginosa.
    Fisher MW
    J Infect Dis; 1974 Nov; 130 Suppl(0):S149-51. PubMed ID: 4138585
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological control of Pseudomonas infection in burn patients: a clinical evaluation.
    Alexander JW; Fisher MW; MacMillan BG
    Arch Surg; 1971 Jan; 102(1):31-5. PubMed ID: 4992359
    [No Abstract]   [Full Text] [Related]  

  • 4. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
    Roe EA; Jones RJ
    Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi.
    Roe EA; Jones RJ
    Rev Infect Dis; 1983; 5 Suppl 5():S922-30. PubMed ID: 6419315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental immunization with attenuated mutants of Pseudomonas aeruginosa.
    Syeklocha D
    Can J Microbiol; 1973 May; 19(5):573-80. PubMed ID: 4196781
    [No Abstract]   [Full Text] [Related]  

  • 8. The epidemiology of Pseudomonas aeruginosa and the development of a polyvalent vaccine.
    Pranter W; Staerk J; Zellner R; Zwisler O
    Prog Immunobiol Stand; 1971; 5():414-8. PubMed ID: 4633968
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
    Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa infection: pathogenesis and therapy.
    Pennington JE
    Compr Ther; 1979 May; 5(5):14-22. PubMed ID: 110508
    [No Abstract]   [Full Text] [Related]  

  • 11. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
    Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
    Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV; Tsyganenko AIa
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa.
    Toama MA; Hamed IM; Ashour SM
    Pharmazie; 1980; 35(4):228-30. PubMed ID: 6773076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.
    Holder IA; Neely AN; Frank DW
    Infect Immun; 2001 Sep; 69(9):5908-10. PubMed ID: 11500471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active immunization of burned patients with a new multivalent Staphylococcus-Pseudomonas vaccine.
    Sachs A
    Prog Immunobiol Stand; 1971; 5():428-32. PubMed ID: 4633971
    [No Abstract]   [Full Text] [Related]  

  • 16. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
    Schiller B; Buchowicz I; Lysakowska E; Sakiel S; Korbecki M
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
    Hunt JL; Purdue GF
    J Trauma; 1988 Feb; 28(2):146-51. PubMed ID: 3126302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous administration of carbenicillin for septicemia due to Pseudomonas aeruginosa following thermal injury.
    Curreri PW; Lindberg RB; DiVincenti FC; Pruitt BA
    J Infect Dis; 1970 Sep; 122():Suppl:S40-7. PubMed ID: 4990024
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of Pseudomonas hyperimmune globulin and plasma.
    Jones CE; Alexander JW; Fisher MW
    Surg Forum; 1970; 21():238-40. PubMed ID: 4105882
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN; Holder IA
    Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.